User:Barbara (WVS)/sandbox/drug micro search templates

https://www.drugs.com/monograph/amitriptyline-hydrochloride.html

Rossi, S, ed. (2013). Australian Medicines Handbook (2013 ed.). Adelaide: The Australian Medicines Handbook Unit Trust. ISBN 978-0-9805790-9-3. ^ Jump up to:a b c Joint Formulary Committee (2013). British National Formulary (BNF) (65th ed.). London, UK: Pharmaceutical Press. ISBN 978-0-85711-084-8. Jump up^ Barbui C, Hotopf M (February 2001). "Amitriptyline v. the rest: still the leading antidepressant after 40 years of randomised controlled trials". The British Journal of Psychiatry. 178 (2): 129–144. . doi:10.1192/bjp.178.2.129. Jump up^ Anderson IM (April 2000). "Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efﬁcacy and tolerability". Journal of Affective Disorders. 58(1): 19–36. . doi:10.1016/S0165-0327(99)00092-0. Jump up^ https://www.ncbi.nlm.nih.gov/pubmed/8736630 Jump up^ Kennea, NL; Evans, JHC (June 2000). "Drug Treatment of Nocturnal Enuresis" (PDF). Paediatric and Perinatal Drug Therapy. Informa Healthcare. 4 (1): 12–18. doi:10.1185/1463009001527679.[permanent dead link] ^ Jump up to:a b Viera AJ, Hoag S, Shaughnessy J (2002). "Management of irritable bowel syndrome" (PDF). Am Fam Physician. 66(10): 1867–74. . Jump up^ Parkinson's disease. Merck Sharp & Dohme Corp. August 2007. Retrieved on 2013-12-22. Jump up^ PJ Millea; JJ Brodie (2002-09-01). "Tension-Type Headache". Am Fam Physician. 66 (5): 797–805. ^ Jump up to:a b c "Levate (amitriptyline), dosing, indications, interactions, adverse effects, and more". Medscape Reference. WebMD. Retrieved 1 December 2013. Jump up^ Flament MF, Bissada H, Spettigue W (March 2012). "Evidence-based pharmacotherapy of eating disorders". International Journal of Neuropsychopharmacology. 15 (2): 189–207. . doi:10.1017/S1461145711000381. Jump up^ Mendelson WB, Roth T, Cassella J, Roehrs T, Walsh JK, Woods JH, Buysse DJ, Meyer RE (February 2004). "The treatment of chronic insomnia: drug indications, chronic use and abuse liability. Summary of a 2001 New Clinical Drug Evaluation Unit meeting symposium". Sleep Med Rev. 8 (1): 7–17. . doi:10.1016/s1087-0792(03)00042-x. Jump up^ Sim Y-J, Kim J-M, Kwon S, Choe B-H (2009). "Clinical experience with amitriptyline for management of children with cyclic vomiting syndrome". Korean Journal of Pediatrics. 52(5): 538–43. doi:10.3345/kjp.2009.52.5.538. Jump up^ Boles RG, Lovett-Barr MR, Preston A, Li BU, Adams K (2010). "Treatment of cyclic vomiting syndrome with co-enzyme Q10 and amitriptyline, a retrospective study". BMC Neurol. 10: 10. PMC 2825193 . . doi:10.1186/1471-2377-10-10. Jump up^ Chung, KF (2008). "Currently available cough suppressants for chronic cough.". Lung. 186 Suppl 1: S82–7. . doi:10.1007/s00408-007-9030-1. Jump up^ Wald, Arnold (2006). "Functional biliary type pain syndrome". In Pasricha, Pankaj Jay; Willis, William D.; Gebhart, G. F. Chronic Abdominal and Visceral Pain. London: Informa Healthcare. pp. 453–62. ISBN 978-0-8493-2897-8. Jump up^ http://www.drugs.com/monograph/amitriptyline-hydrochloride.html Jump up^ http://gi.org/guideline/management-of-gastroparesis ^ Jump up to:a b "Amitriptyline Tablets BP 50mg - Summary of Product Characteristics (SPC)". electronic Medicines Compendium. Actavis UK Ltd. 24 March 2013. Retrieved 1 December 2013. ^ Jump up to:a b Wesley R. Zemrak, Pharm.D.; George A. Kenna, Ph.D., B.S.Pharm (2008). "Association of Antipsychotic and Antidepressant Drugs With Q-T interval Prolongation". WebMD LLC. Retrieved January 14, 2017. ^ Jump up to:a b c d e f g h i j k l m n o p q "Endep Amitriptyline hydrochloride" (PDF). TGA eBusiness Services. Alphapharm Pty Limited. 10 December 2012. Retrieved 1 December 2013. Jump up^ Roth, BL; Driscol, J. "PDSP Ki Database" (HTML). Psychoactive Drug Screening Program (PDSP). University of North Carolina at Chapel Hill and the United States National Institute of Mental Health. Retrieved 14 August 2017. ^ Jump up to:a b c d e Tatsumi M, Groshan K, Blakely RD, Richelson E (1997). "Pharmacological profile of antidepressants and related compounds at human monoamine transporters". Eur. J. Pharmacol. 340 (2-3): 249–58. . ^ Jump up to:a b c d e Owens MJ, Morgan WN, Plott SJ, Nemeroff CB (1997). "Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites". J. Pharmacol. Exp. Ther. 283 (3): 1305–22. . ^ Jump up to:a b c d e f g Cusack B, Nelson A, Richelson E (1994). "Binding of antidepressants to human brain receptors: focus on newer generation compounds". Psychopharmacology (Berl.). 114 (4): 559–65. . ^ Jump up to:a b Peroutka SJ (1988). "Antimigraine drug interactions with serotonin receptor subtypes in human brain". Ann. Neurol. 23(5): 500–4. . doi:10.1002/ana.410230512. Jump up^ Peroutka SJ (1986). "Pharmacological differentiation and characterization of 5-HT1A, 5-HT1B, and 5-HT1C binding sites in rat frontal cortex". J. Neurochem. 47 (2): 529–40. . Jump up^ Roth BL, Kroeze WK (2006). "Screening the receptorome yields validated molecular targets for drug discovery". Curr. Pharm. Des. 12 (14): 1785–95. . Jump up^ Pälvimäki EP, Roth BL, Majasuo H, Laakso A, Kuoppamäki M, Syvälahti E, Hietala J (1996). "Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2c receptor". Psychopharmacology (Berl.). 126 (3): 234–40. . Jump up^ Kohen R, Metcalf MA, Khan N, Druck T, Huebner K, Lachowicz JE, Meltzer HY, Sibley DR, Roth BL, Hamblin MW (1996). "Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor". J. Neurochem. 66 (1): 47–56. . Jump up^ Hirst WD, Abrahamsen B, Blaney FE, Calver AR, Aloj L, Price GW, Medhurst AD (2003). "Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modeling". Mol. Pharmacol. 64 (6): 1295–308. . doi:10.1124/mol.64.6.1295. Jump up^